Jaylen Brown Cleared for Celtics Playoff Opener After Achilles Injury

**Jaylen Brown is cleared for the Celtics’ playoff opener against the 76ers after sitting out the regular-season finale with Achilles tendinitis.** He averaged 30.6 points per game in April over five contests.

## Context The Boston Celtics enter the Eastern Conference playoffs with a full roster as their star wing returns from a brief absence. Brown missed the final regular‑season game due to Achilles tendinitis, an inflammation of the tendon that connects the calf muscles to the heel. The team listed him as day‑to‑day but removed him from the injury report ahead of Game 1.

His availability matters because Boston relies on his scoring and playmaking to complement Jayson Tatum. In the regular season, Brown averaged 27.4 points, 6.1 rebounds and 3.5 assists per game, ranking among the league’s top two‑way guards. The April stretch showed he can elevate his output when needed.

Brown has appeared in 45 playoff games for Boston, averaging 19.3 points and 5.2 rebounds.

## Key Facts Brown is not on the injury report for the Celtics’ Game 1 matchup against the Philadelphia 76ers.

He missed the regular‑season finale with Achilles tendinitis but is ready for the playoffs.

In five April appearances he averaged 30.6 points, 4.8 rebounds, 3.6 assists and 1.2 steals in 34.8 minutes per game.

## What It Means His return gives Boston a second scoring option capable of creating his own shot, which could ease pressure on Tatum in close games. The Celtics’ offensive rating improves when both wings are on the floor together, based on season data.

Opponents will likely adjust defensive schemes to limit Brown’s mid‑range and drives, potentially opening lanes for Boston’s role players. The health of his Achilles will be monitored throughout the series. His ability to draw fouls also increases Boston’s free‑throw attempts, adding another scoring avenue.

## What to Watch Next Watch how Brown’s minutes and production evolve in Game 1 and whether the Achilles remains symptom‑free as the series progresses.